Wölfel T - Search Results

1

Immunotherapy of cancer: from vision to standard clinical practice.

Huber CH, Wölfel T. Huber CH, et al. Among authors: wolfel t. J Cancer Res Clin Oncol. 2004 Jul;130(7):367-74. doi: 10.1007/s00432-004-0550-2. J Cancer Res Clin Oncol. 2004. PMID: 15067541 Review.

2

T cell responses to human malignant tumours.

Knuth A, Wölfel T, Meyer zum Büschenfelde KH. Knuth A, et al. Among authors: wolfel t. Cancer Surv. 1992;13:39-52. Cancer Surv. 1992. PMID: 1423325 Review.

3

Cellular and humoral immune responses against cancer: implications for cancer vaccines.

Knuth A, Wölfel T, Meyer zum Büschenfelde KH. Knuth A, et al. Among authors: wolfel t. Curr Opin Immunol. 1991 Oct;3(5):659-64. doi: 10.1016/0952-7915(91)90093-g. Curr Opin Immunol. 1991. PMID: 1755985 Review.

4

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.

Knuth A, Wölfel T, Klehmann E, Boon T, Meyer zum Büschenfelde KH. Knuth A, et al. Among authors: wolfel t. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2804-8. doi: 10.1073/pnas.86.8.2804. Proc Natl Acad Sci U S A. 1989. PMID: 2784858 Free PMC article.

5

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.

Wölfel T, Klehmann E, Müller C, Schütt KH, Meyer zum Büschenfelde KH, Knuth A. Wölfel T, et al. J Exp Med. 1989 Sep 1;170(3):797-810. doi: 10.1084/jem.170.3.797. J Exp Med. 1989. PMID: 2788708 Free PMC article.

6

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D. Wölfel T, et al. Among authors: wolfel c. Science. 1995 Sep 1;269(5228):1281-4. doi: 10.1126/science.7652577. Science. 1995. PMID: 7652577

7

Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL).

Wölfel T, Hauer M, Klehmann E, Brichard V, Ackermann B, Knuth A, Boon T, Meyer Zum Büschenfelde KH. Wölfel T, et al. Int J Cancer. 1993 Sep 9;55(2):237-44. doi: 10.1002/ijc.2910550212. Int J Cancer. 1993. PMID: 7690346

8

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.

Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH, et al. Bernhard H, et al. Among authors: wolfel t, wolfel c. Int J Cancer. 1994 Dec 15;59(6):837-42. doi: 10.1002/ijc.2910590621. Int J Cancer. 1994. PMID: 7989126

9

Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells.

Herr W, Wölfel T, Heike M, Meyer zum Büschenfelde KH, Knuth A. Herr W, et al. Among authors: wolfel t. Cancer Immunol Immunother. 1994 Aug;39(2):93-9. doi: 10.1007/BF01525314. Cancer Immunol Immunother. 1994. PMID: 8044834

10

Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1.

Wölfel T, Schneider J, Meyer Zum Büschenfelde KH, Rammensee HG, Rötzschke O, Falk K. Wölfel T, et al. Int J Cancer. 1994 May 1;57(3):413-8. doi: 10.1002/ijc.2910570320. Int J Cancer. 1994. PMID: 8169004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results